Targeting Interleukin-6/Glycoprotein-130 Signaling by Raloxifene or SC144 Enhances Paclitaxel Efficacy in Pancreatic Cancer

SIMPLE SUMMARY: Pancreatic cancer is presently the fourth most common cause of cancer-related death. Treatment options and prognosis are poor. Therefore, new therapeutic approaches are urgently needed. Molecular targeting of the interleukin-6/glycoprotein-130/signal transducer and activator of trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Hering, Nina A., Günzler, Emily, Arndt, Marco, Zibell, Miriam, Lauscher, Johannes C., Kreis, Martin E., Beyer, Katharina, Seeliger, Hendrik, Pozios, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856922/
https://www.ncbi.nlm.nih.gov/pubmed/36672405
http://dx.doi.org/10.3390/cancers15020456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856922/
https://www.ncbi.nlm.nih.gov/pubmed/36672405
http://dx.doi.org/10.3390/cancers15020456

Ejemplares similares